CD4+ T cells display an antitumor immunity profile by enhancing the antineoplastic effect at the tumor site, preventing activation-induced cell death, and giving priority to the generation of immune memory cells by cytotoxic T-lymphocytes [27]. This evidence concerns the gene CD4 and neoplasm.